A detailed history of Farallon Capital Management LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 27,600 shares of ALT stock, worth $232,668. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,600
Previous 27,600 -0.0%
Holding current value
$232,668
Previous $183,000 7.65%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$5.91 - $10.23 $2.61 Million - $4.53 Million
-442,400 Reduced 94.13%
27,600 $183,000
Q1 2024

May 15, 2024

BUY
$8.22 - $13.81 $3.58 Million - $6.02 Million
436,000 Added 1282.35%
470,000 $4.78 Million
Q4 2023

Feb 14, 2024

BUY
$2.14 - $11.62 $72,760 - $395,080
34,000 New
34,000 $382,000

Others Institutions Holding ALT

About Altimmune, Inc.


  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $413M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.